Tahseen, S <br/><br/>
Use of Xpert(®) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.  [electronic resource] 

 -  The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease  Apr 2016 
 - 448-55 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1815-7920 
<br/><br/><label>Standard No.: </label>10.5588/ijtld.15.0645  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibiotics, Antitubercular--therapeutic use<br/>Cluster Analysis<br/>Cross-Sectional Studies<br/>Drug Resistance, Multiple, Bacterial<br/>Feasibility Studies<br/>Female<br/>Humans<br/>Logistic Models<br/>Male<br/>Microbial Sensitivity Tests--methods<br/>Middle Aged<br/>Mycobacterium tuberculosis--drug effects<br/>Pakistan<br/>Prevalence<br/>Reproducibility of Results<br/>Rifampin--therapeutic use<br/>Sensitivity and Specificity<br/>Sputum--microbiology<br/>Surveys and Questionnaires<br/>Tuberculosis, Multidrug-Resistant--diagnosis<br/>Young Adult